Henholdsvis 0, 6% og 0% af patienterne oplevede hypotension og henholdsvis 2, 8% og 3, 1% oplevede svimmelhed i ved kombinationsbehandling og enkeltstofbehandling.
There were 0. 6% and 0% of patients with hypotension and 2. 8% and 3. 1% of patients with dizziness as adverse reactions reported in the combination and monotherapy groups, respectively.